Post-earnings recap
Reported
Thu, Feb 27, 2025
EPS actual
$1.75
EPS est.
$1.41
EPS surprise
+24.11%
1-day move
+0.25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a strong earnings per share, exceeding expectations by over 24%. However, there was no revenue data provided, leaving some uncertainty. The stock reacted positively, increasing by 0.25%, likely reflecting investor confidence in the EPS performance despite the lack of additional details.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.75 | N/A | +24.11% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.